Further studies have demonstrated beneficial effects in patients with CHF due to both ischemic and idiopathic dilated cardiomyopathy with improvements in hemodynamics when GH was added both as a maintenance therapy and as short-term infusion [119, 120]. The gene discussed is GH1; the disease is congestive heart failure.